CI 1030

a dopamine D4 receptor antagonist; structure in first source

Also Known As:

7-(4-(4-chlorophenyl)piperazin-1-ylmethyl)-4H-benzo(1,4)oxazin-3-one; CI-1030; CI1030

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Renal Insufficiency (Renal Failure) 07/01/1989 - "There were no differences (based on MI results) between the two groups for elimination half-life (T1/2 beta) (renal failure: 188 min; anaesthetized controls: 195 min), clearance (CI) (1030 and 1093 ml min-1) and apparent volume of distribution at steady state (Vss) (223.0 and 215.3 litre). "